Medical devices in dermatology: Topical semi-solid formulations for the treatment of skin diseases;Medizinprodukte in der Dermatologie: Topische halbfeste Formulierungen zur Behandlung von Hauterkrankungen

JDDG - Journal of the German Society of Dermatology

Volumn 10, Issue 2, 2012, Pages 103-109

  Korting, Hans Christian ^a   Schöllmann, Claudia ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

actinic keratosis; atopic dermatitis; head lice; medical device; radiation induced dermatitis; scars

Indexed keywords

CERTIFICATION; CONTROLLED STUDY; DEVICE THERAPY; DRUG EFFECT; EVIDENCE BASED MEDICINE; MEDICAL INSTRUMENTATION; REVIEW; SKIN DISEASE;

EID: 84857044635     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2011.07764.x     Document Type: Review

References (38)

1. Schorn G,. MPG Medizinproduktege-setz, 4. Auflage, Wissenschaftliche Ver-lagsgesellschaft, Stuttgart, 2009.
2. Platzek T, Krätke R, Schulz C,. Kosme-tische Mittel- Sicherheitsaspekte. Bundesgesundheitsblatt 2010; 53: 610-4.
3. Rogiers V, Pauwels M,. Cosmetic products and their current European regulatory framework. Curr Probl Derma-tol 2008; 36: 1-28.
4. Schlemminger M,. The proof of the pudding-die Zulassung. In:, Dagmar Fischer, Jörg Breitenbach, (Hrsg.): Die Pharmaindustrie. 2. Auflage, Heidelberg: Spektrum Akademischer Verlag, 2010.
5. Korting HC,. Evidenzbasierte Derma-tika und Kosmetika. In:, Plewig G, Kaudewitz P, Sander CA, (Hrsg.): Fort-schritte der praktischen Dermatologie und Venerologie. Band 19, Berlin: Springer, 2004: 548-54.
6. Pavicic T, Steckmeier S, Kerscher M, Korting HC,. Evidenzbasierte Kosme-tika: Konzepte und Anwendung bei den Zielstellungen Cellulite, Striae di-stensae und Acne vulgaris. Geburtsh Frauenheilk 2007; 68: 986-9.
7. Korting HC, Borelli C, Schöllmann C,. Acne vulgaris. Rolle der Kosmetik. Hautarzt 2010; 61: 126-31.
8. Getting medical devices faster to market. Med Device Technol 2007; 18: 52.
9. Patrizi A, Raone B, Neri I,. Atopiclair. Expert Opin Pharmacother 2009; 10: 1223-30.
10. Hanifin JM, Rajka G,. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92 (Suppl.): 44-7.
11. Cork MJ, Danby SG, Vasiloupoulos Y, Hadgraft J, Lane E, Moustafa M, Guy RH, MacGowan AL, Tazi-Ahnini R, Ward SJ,. Epidermal barrier dysfunction in atopic dermatitis. J Invest Der-matol 2009; 129: 1892-908.
12. Boguniewicz M, Leung DYM,. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 2010; 125: 4-13.
13. Abramovits W, Hebert AA, Boguniewicz M, Kempers SE, Tschen E, Jarratt MT, Lucky AW, Cornelison RL, Swinyer LJ, Jones TM,. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults. J Dermatolog Treat 2008; 19: 327-32.
14. Belloni G, Pinelli S, Veraldi S,. A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis. Eur J Dermatol 2005; 15: 31-6. (Pubitemid 40254620)
15. Patrizi A, Capitanio B, Neri I, Giacomini F, Sinagra JL, Raone B, Berardesca E,. A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR) in the management of atopic dermatitis in pa-ediatric patients. Pediatr Allergy Immunol 2008; 19: 619-25.
16. Boguniewicz M, Zeichner JA, Eichenfield LF, Hebert AA, Jarratt M, Lucky AW, Paller AS,. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study. J Pediatr 2008; 152: 854-9.
17. King KB, Nail LM, Kreamer K, Strohl RA, Johnson JE,. Patients' descriptions of the experience of receiving radiation therapy. Oncol Nurs Forum 1985; 12: 55-61.
18. Leonardi MC, Gariboldi S, Ivaldi GB, Ferrari A, Serafini F, Didier F, Mariani L, Castiglioni S, Orecchia R,. A double-blind, randomised, vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin: interim analysis. Eur J Dermatol 2008; 18: 317-21. (Pubitemid 351821237)
19. Primavera G, Carrera M, Berardesca E, Pinnarõ P, Messina M, Arcangeli G,. A double-blind, vehicle-controlled clinical study to evaluate the efficacy of MAS065D (XClair), a hyaluronic acid-based formulation, in the management of radiation-induced dermatitis. Cutan Ocul Toxicol 2006; 25: 165-71. (Pubitemid 44410610)
20. Veraldi S, Menter A, Innocenti M,. Treatment of mild to moderate seborr-hoeic dermatitis with MAS064D (Seb-clair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial. J Eur Acad Der-matol Venereol 2008; 22: 290-6. (Pubitemid 351255418)
21. Röwert-Huber J, Patel MJ, Forschner T, Ulrich C, Eberle J, Kerl H, Sterry W, Stockfleth E,. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Der-matol 2007; 156 (Suppl 3): 8-12. (Pubitemid 46632512)
22. Moy RL,. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: 8-10.
23. Wlaschek M, Tantcheva-Poõr I, Naderi L, Ma W, Schneider LA, Razi-Wolf Z, Schüller J, Scharffetter-Kochanek K,. Solar UV irradiation and dermal pho-toaging. J Photochem Photobiol B 2001; 63: 41-51.
24. Terhorst D, Stockfleth E,. Therapie epithelialer Tumoren. Akt Dermatol 2008; 34: 482-6.
25. Ulrich M, Drecoll U, Stockfleth E,. Emerging drugs for actinic keratosis. Expert Opin Emerg Drugs 2010; 15: 545-55.
26. Ulrich C, Degen A, Patel MJ, Stockfleth E,. Sunscreens in organ transplant patients. Nephrol Dial Transplant 2008; 23: 1805-8. (Pubitemid 351768204)
27. Roberts RJ, Burgess I F,. New head-lice treatments: hope or hype? Lancet 2005; 365: 8-9.
28. Richter J, Müller-Stöver I, Walter S, Mehlhorn H, Häussinger, D,. Kopf-läuse-Umgang mit einer wieder aufle-benden Parasitose. Dtsch Arztebl 2005; 102: A-2395/B-2016/C-1909.
29. Mehlhorn H, (Hrsg.). Encylopedic references of parasitology. 1. Auflage, Springer Verlag, Berlin, 2002: 339-41.
30. Richling I, Böckeler W,. Lethal Effects of Treatment with a Special Dimeticone Formula on Head Lice and House Crickets (Orthoptera, Ensifera: Acheta domestica and Anop-lura, Phthiraptera: Pediculus humanus). Arzneimittel- Forschung 2008; 58: 248-54. (Pubitemid 351798785)
31. Â L, a pediculicide containing dimeticone. J Eur Acad Dermatol Venereol 2007; 21: 1325-9. (Pubitemid 350027158)
32. Heukelbach J, Asenov A, Liesenfeld O, Mirmohammadsadegh A, Oliveira FA,. A new two-phase dimeticone pediculi-cide shows high efficacy in a comparative bioassay. BMC Dermatol 2009; 9: 12.
33. Sonnberg S, Oliveira FA, de Melo ILA, de Melo Soares MM, Becher H, Heukelbach J,. Ovizide Wirksamkeit von over-the-counter Kopflausproduk-ten. Poster10-33-17 (Postersession 38-34-4), präsentiert bei der104. Jahresta-gung der Deutschen Gesellschaft für Kinder- und Jugendmedizin in Mün-chen 2008.
34. Heukelbach J, Pilger D, Oliveira FA, Khakban A, Ariza L, Feldmeier H,. A highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial. BMC Infect Dis 2008; 8: 115.
35. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, Stella M, Téot L, Wood FM, Zieg-ler UE,; International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg 2002; 110: 560-71. (Pubitemid 34815962)
36. Mustoe TA,. Evolution of silicone therapy and mechanism of action in scar management. Aesthetic Plast Surg 2008; 32: 82-92.
37. Chernoff WG, Cramer H, Su-Huang S,. The efficacy of topical silicone gel elastomers in the treatment of hyper-trophic scars, keloid scars, and post-laser exfoliation erythema. Aesthetic Plast Surg 2007; 31: 495-500. (Pubitemid 47437499)
38. Signorini M, Clementoni MT,. Clinical evaluation of a new self-drying silicone gel in the treatment of scars: a preliminary report. Aesthetic Plast Surg 2007; 31: 183-7. (Pubitemid 46625377)